Filing Details
- Accession Number:
- 0001104659-19-041307
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-22 16:32:02
- Reporting Period:
- 2019-07-22
- Accepted Time:
- 2019-07-22 16:32:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1680581 | Fulcrum Therapeutics Inc. | FULC | Pharmaceutical Preparations (2834) | 474839948 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1717958 | 6 Dimensions Capital, L.p. | Po Box 309, Ugland House Grand Cayman, Cayman Islands KY 1-1104 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-22 | 441,071 | $0.00 | 441,071 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2019-07-22 | 118,750 | $16.00 | 559,821 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2019-07-22 | 3,087,500 | $0.00 | 441,071 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- On July 22, 2019 the Series B Preferred Stock converted into Common Stock on 7:1 basis upon the closing of the issuer's initial public offering without payment of consideration. The shares had no expiration date.